Methods Molecular markers [von Willebrand factor(vWF),GMP-140,11-DH-TXB_2,FIB,AT] and tissue-type plasminogenactivator(t-PA),PAI-1,as well as hemodynamic indexes were analyzed.
Methods Molecular markers [von Willebrand factor(vWF),GMP-140,11-DH-TXB_2,FIB,AT] and tissue-type plasminogenactivator(t-PA),PAI-1,as well as hemodynamic indexes were analyzed.
目的通过观察原发性高血压患者血栓前状态(PTS)分子标志物的变化,探讨其易并发血栓性疾病的机制,为临床早期诊治提供客观依据。